Chris Degnan
Financieel Directeur/CFO bij GALERA THERAPEUTICS, INC.
Vermogen: 2 070 $ op 30-04-2024
Actieve functies van Chris Degnan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Financieel Directeur/CFO | 21-10-2019 | - | |
Investor Relations Contact | 21-10-2019 | - | |
Bedrijfssecretaris | 21-10-2019 | - |
Loopbaan van Chris Degnan
Eerdere bekende functies van Chris Degnan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01-03-2018 | 07-10-2019 |
Financieel Directeur/CFO | 01-03-2018 | 07-10-2019 | |
ENDO INTERNATIONAL PLC | Financieel Directeur/CFO | 01-11-2014 | 01-03-2018 |
ASTRAZENECA PLC | Financieel Directeur/CFO | 01-01-2004 | 01-11-2014 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Financieel Directeur/CFO | - | - |
Opleiding van Chris Degnan
University of Notre Dame | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Ierland | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Beurs
- Insiders
- Chris Degnan
- Ervaring